Skip to content

Clinical trials

Dyslipidemias trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Country / region: Switzerland Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20041
20063
20111
20131
20141
20151
20161
20172
20202
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting2
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi3
Amgen2
University Hospital, Basel, Switzerland2
Centre Hospitalier Universitaire Vaudois1
Clarunis - Universitäres Bauchzentrum Basel1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1
Foundation for Cardiovascular Research, Zurich1
Newcastle University1
Novartis1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias19
Obesity6
Diabetes Mellitus, Type 25
Cardiovascular Diseases4
Fatty Liver3
HIV Infections3
Hypercholesterolemia3
Metabolic Syndrome3
Atherosclerosis2
Coronary Artery Disease2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.